Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro

European Respiratory Journal

Volumn 18, Issue 1, 2001, Pages 122-129

  Feldman, C ^a   Anderson, R ^a   Theron, A J ^a   Steel, H C ^a   van Rensburg, C E J ^a   Cole, P J ^a   Wilson, R ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Airway inflammation; Ciliary beat frequency; Epithelial damage; Lysophosphatidylcholine; Platelet activating factor; Polymorphonuclear leukocytes

Indexed keywords

1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE; ALPHA TOCOPHEROL; ANTIOXIDANT; LUCIGENIN; LYSOPHOSPHATIDYLCHOLINE; OXIDIZING AGENT; PHOSPHOLIPID; STABILIZING AGENT; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR;

AIRWAY; ARTICLE; ASSAY; ATTENUATION; CHEMOLUMINESCENCE; CHRONIC INFLAMMATION; CILIARY MOTILITY; CILIATED EPITHELIUM; CONTROLLED STUDY; CYTOTOXICITY; DISEASE PREDISPOSITION; DRUG EFFECT; HEMOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; MEDIATOR; MEMBRANE DAMAGE; MEMBRANE STABILIZATION; MEMBRANE STRUCTURE; NEUTROPHIL; NORMAL HUMAN; PATHOGENESIS; PHAGOCYTE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SEMICONDUCTOR; SPECTROPHOTOMETRY; TECHNIQUE; VISION;

CELLS, CULTURED; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MUCOCILIARY CLEARANCE; NASAL MUCOSA; PHOSPHOLIPIDS; PLATELET ACTIVATING FACTOR; VITAMIN E;

EID: 0034901140     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.00037401     Document Type: Article

References (50)

1. Platelet-activating factor: A fluid phase and cell-associated mediator of inflammation
2. Lysophosphatidylcholine induces mast cell secretion and protein kinase C activation
3. Lysophosphatidylcholine stimulates leukocyte rolling and adherence in rat mesenteric microvasculature
4. Regulation of protein kinase C by lysophospholipids: Potential role in signal transduction
5. Lysophosphatidylcholine generates superoxide anion through activation of phosphatidylinositol 3-kinase in human neutrophils
6. 2 in inflammatory diseases
7. 2 regulates critical inflammatory mediators of multiple organ failure
8. Lysophosphoglycerides in ischemic myocardium effluents and potentiation of their arrhythmogenic effects
9. Lysophosphatidylcholine accumulation in ischemic human myocardium
10. Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses
11. 2 activity and plasma lysophosphatidylcholine in asthma and rhinitis and their relationship to airway sensitivity to histamine
12. Antigen-induced generation of lyso-phospholipids in human airways
13. Platelet activating factor as a mediator of allergic disease
14. The sirens' song of confirmatory sepsis trials: Selection bias and sampling error
15. Effect of the platelet-activating factor antagonist UK-75,505 on the early and late responses to allergen
16. Effect of a platelet-activating factor antagonist, WEB 2086, on allergen-induced asthmatic responses
17. Effects of amphiphiles on erythrocytes, coronary arteries, and perfused hearts
18. Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma
19. 2, free fatty acids and lysophospholipids
20. +-adenosine triphosphatase is a possible mechanism of immuno-suppressive activity of cyclosporin A
21. Increased platelet-activating factor (PAF) synthesis in polymorphonuclear leukocytes of vitamin E-deficient rats
22. Vitamin E, pulmonary functions, and phagocyte-mediated oxidative stress in smokers and nonsmokers
23. Dietary antioxidant vitamin intake and lung function in the general population
24. Does dietary intake of vitamins C and E influence lung function in older people?
25. Correlation of antioxidant vitamin intake and lung function in adults
26. A prospective study of diet and adult-onset asthma
27. Antioxidant intake and adult wheeze: A case-control study
28. Non-invasive sampling of nasal cilia for the measurement of beat frequency and ultrastructure
29. A photo-transistor technique for the measurement of the ciliary beat frequency of human ciliated epithelium in vitro
30. The effect of erythromycin on Pseudomonas aeruginosa and neutrophil mediated epithelial damage
31. Formation of α-tocopherol complexes with fatty acids: A hypothetical mechanism of stabilization of biomembranes by vitamin E
32. Altered lung antioxidant status in patients with mild asthma
33. Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro
34. 1-0-Hexadecyl-2-acetyl-sn-glycero-3-phospho(N,N,N trimethyl)hexanolamine: An analogue of platelet-activating factor with partial agonist activity
35. Lysophosphatides enhance superoxide responses of stimulated neutrophils
36. Vitamin E is a potent inhibitor of superoxide generation by neutrophils activated with soluble, but not particulate stimuli of membrane-associated oxidative metabolism
37. Vitamin E: A sensor and an information transducer of the cell oxidation state
38. Alpha-tocopherol inhibits the respiratory burst in human monocytes - Attenuation of p47(Phox) membrane translocation and phosphorylation
39. Protease priming of neutrophil superoxide production: Effects on membrane lipid order and lateral mobility
40. Anti-inflammatory, membrane-stabilizing interactions of salmeterol with human neutrophils in vitro
41. Oxidant-mediated ciliary dysfunction in human respiratory epithelium
42. Mechanisms of hypochlorite injury of target cells
43. Oxidant injury of cells: DNA strand breaks activate poly-ADP-ribose polymerase and lead to depletion of NAD
44. Electrophysiologic effects of intracellular lysophosphoglycerides and their accumulation in cardiac lymph in dogs with myocardial ischemia
45. Deficiency of vitamin E in the alveolar fluid of cigarette smokers
46. 2 in the alteration of surfactant function in patients with pneumonia
47. Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury
48. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice
49. 2+ signaling via the platelet-activating factor receptor in macrophages
50. 2+ signaling via platelet-activating factor receptor